| |
|
|
|
LA Jolla Pharma  
|
|
3.97 -0.2 (-0.05%) |
09-28 16:00 |
|
Open: |
4.04 |
Pre close: |
4.17 |
Target:
|
4.93 
|
|
High: |
4.0995 |
Low: |
3.85 |
Resistance:
|
4.22
4.47
|
|
Volume: |
139,752 |
Market Cap: |
109M |
Support:
|
3.82
3.18
|
|
|
|
|
|
Technical Analysis |
|
Moving Averages |
MA(5):
|
4.06
 |
MACD |
MACD(12,26):
|
0.00 |
|
MA(20): |
4.09 |
Signal(12,26,9): |
0.02 |
|
MA(100): |
4.12 |
Stochastic Oscillator |
%K(14,3):
|
30.74 |
|
MA(250): |
4.50 |
%D(3): |
36.47 |
|
Average Volume(K) |
3-Month: |
498869
|
52-Week |
High:
|
7.85 |
|
10-Days: |
9202 |
Low: |
3.35 |
|
RSI |
RSI(14):
|
45.77 |
Change(%): |
-1.5 |
|
Financials, Statistics and Valuation |
|
EPS |
-0.599 |
Return on Equity (ttm) |
0.0 |
Shares Out. (M) |
27.47 |
|
EPS Est. Current Year |
-4.990 |
Return on Assets (ttm) |
1.8 |
Shares Float (M) |
13.63 |
|
EPS Est. Next Year |
-3.970 |
PEG Ratio |
0.00 |
% Held by Insiders |
1.67 |
|
EPS Est. Next Quarter |
-1.420 |
Qtrly Rev. Growth |
349.7 |
% Held by Institutions |
78.82 |
|
Forward EPS |
-7.850 |
Gross Profit (p.s.) |
1.021 |
Shares Short (K) |
2340 |
|
Book Value (p.s.) |
-2.780 |
EBITDA (p.s.) |
0.187 |
P/E |
-6.63 |
|
Sales Per Share |
2.183 |
Qtrly Earnings Growth |
0.00 |
P/BV |
-1.43 |
|
Profit Margin |
-27.37 |
Operating Cash Flow
(M) |
-8.21 |
P/S |
1.82 |
|
Operating Margin |
4.91 |
Levered Free Cash Flow
(M) |
-4.95 |
P/CF |
-13.28 |
|
|
|
|
|
|
